Author:
García Mauricio A.,Cristofoletti Rodrigo,Abrahamsson Bertil,Groot Dirk W.,Parr Alan,Polli James E.,Mehta Mehul,Shah Vinod P.,Tomakazu Tajiri,Dressman Jennifer B.,Langguth Peter
Reference105 articles.
1. World Health Organization, WHO Technical Report Series, No 937. Annex 8. Proposal to Waive In Vivo Bioequivalence Requirements for WHO Model List of Essential Medicines Immediate-Release, Solid Oral Dosage Forms,2006
2. 21st Edition World Health Organization. WHO Model List of Essential Medicines,2019
3. 7th Edition World Health Organization. WHO Model List of Essential Medicines for Children,2019
4. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
5. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence,2010
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献